SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
A trial investigating the effects of pyridostigmine (mestinon) versus a placebo in a double-blind cross over trial in patients with hereditary proximal spinal muscular atrophy (SMA) types 2, 3 and 4.
Epistemonikos ID: 4d9cff71f9d7a8b3961b5f5ff8ff7f48cf0c3eac
First added on: May 17, 2024